| |
|
|
| |
|
| Teodoro del Ser |
| Physiopathology |
 |
What is Alzheimer’s Disease? |
 |
Established theoretical frameworks to explain AD |
 |
Pharmacological Approaches |
|
|
 |
| |
| Alberto Lleó |
| Vaxine |
 |
Inmunotherapy for AD |
|
|
 |
| |
| Linda Teri |
| Pleasant event intervention |
 |
What is the Seattle Protocol? |
 |
What activities do the patients participate in? |
 |
Results |
 |
Benefits of Physical Exercise |
 |
How to balance Non Pharmacological Interventions(NPI) |
|
|
 |
| |
| Linda Clare |
| Phenomenology of interventions |
 |
How does it feel to have AD? |
 |
Different ways of coping whit AD |
 |
Are NPI sufficiently available? |
 |
Do NPI need to be tailored individually? |
 |
What are the effects of not delivering NPI? |
 |
Are NPI easily deliverable in institutions? |
|
|
 |
| |
|
|
| Miia Kivipelto |
| Physical Exercise |
 |
How to reduce the risk of suffering from AD. |
 |
Cases Where there is no effective way to prevent the AD. |
 |
Risk factors |
|
|
 |
| |
|
| |
| Sunnie Kenowski |
| NPT and Politics |
 |
Are NPI used appropriately in the US? |
 |
How can NPT be rationally integrated in standard dementia care? |
|
|
 |
| |
|
|
| |
| Barry Reisberg |
| Retrogenesis as treatment framework |
 |
What is retrogenesis? |
 |
How Many typical stages have been identified in AD? |
 |
What are the differences between AD patients and children? |
 |
What domains are subject to retrogenetic process? |
 |
Is there a correspondence to children developmental age? |
 |
What needs do children and AD patients share? |
 |
How do you envisage AD care? |
 |
What is the toughest AD Stage? |
 |
Is there a link between symptoms of AD and how the patient was in the past? |
|
|
 |
| |
|
|
| |
| Javier Olazarán |
| Cognitive intervention and staging |
 |
In what stages are cognitive interventions appropriate? |
 |
Do NPTS make sense for severe dementia? |
 |
What is the role of NPTs in dementia care? |
 |
Do different stages of the illness require different treatments? |
 |
What is the role of love in AD care? |
|
|
 |
| |
|
|
| |
| Cleusa Ferri |
| Racial and continental differences for NPT |
 |
Does epidemiology vary over continents or between developed and developing countries? |
 |
What is the role of education in Ad? |
 |
Do BPSD vary among Continents? |
 |
What is the role of NPT in developing countries? |
|
|
 |
| |
|
|
| |
| Howard Feldman |
| Pharmacological treatment |
 |
What types of pharmacological treatment are there available? |
 |
What is the benefit of AD drugs? |
|
|
 |
| |
|
|
| |
| Rubén Muñiz |
| NPT Project objectives |
 |
What is the Objective of NPT Conference? |
 |
What is the purpose of NPT? |
|
|
 |
| |
|
|
| |
| Aimee Spector |
| Reminiscence, cognitive stimulation, validation |
 |
Types of NPI available |
|
|
 |
| |
|
|
| |
| Mary Mittelman |
| Caregiver interventions |
 |
A randomized controled trial on care giver intervention |
 |
Short and long term effects |
|
|
 |
| |
|
|
| |
| Jordi Peña-Casanova |
| Combining pharma and non-pharma |
 |
What is the relevance of NPI in AD treatment? |
|
|
 |
| |
|
|